Obesity, Fatty Liver and Liver Cancer

  • Jun Yu

Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 1061)

Table of contents

About this book


This volume covers a state-of-the-art illustration of recent discoveries concerning obesity-related fatty liver diseases and liver cancer. The contents are extensive and comprehensive. It brings important topics in the field all together under one umbrella, from epidemiology and etiology, molecular pathogenesis, cellular biology, epigenetics, immunology, microbiology, animal models to therapeutic approaches and treatments. All the book contributors are leading experts in the field. It will appeal to researchers, clinicians and graduate students in obesity, fatty liver diseases, GI/Liver cancer field. It may also yield benefits for pharmaceutical companies with regard to drug discovery.


non-alcoholic fatty liver disease (NAFLD) non-alcoholic steatohepatitis (NASH) hepatocellular carcinoma (HCC) obesity Liver cancer GI cancer Liver fibrosis

Editors and affiliations

  • Jun Yu
    • 1
  1. 1.Institute of Digestive Disease and Department of Medicine & Therapeutics State Key Laboratory of Digestive Disease LKS Institute of Health SciencesThe Chinese University of Hong KongHong KongHong Kong

Bibliographic information